集中式疫苗提醒/召回对成人疫苗接种效果的随机对照试验
该实用性随机对照试验利用科罗拉多州免疫信息系统,将丹佛健康中心患者按年龄和风险分层后随机接受最多三次集中式提醒/召回或常规护理,评估6个月内任何所需疫苗接种记录。结果仅≥65岁人群干预与接种相关(AOR=1.15,95%CI=1.02,1.30),差异源于流感疫苗(干预组32.0% vs 常规护理组28.6%,p≤0.01),人均启动和实施成本0.86美元。
要点
- 集中式提醒/召回与≥65岁成人任何所需疫苗接种相关(AOR=1.15,95%CI=1.02,1.30)。
- 19-64岁无高风险条件及有高风险条件人群未见显著关联。
- 流感疫苗接种率干预组32.0% vs 常规护理组28.6%(p≤0.01)。
核心结论
- 集中式提醒/召回在短时间内有效提高≥65岁成人流感疫苗接种率,不增加诊所负担且成本合理。
研究设计与样本
- 实用性随机对照试验,丹佛健康中心患者分为三层:19-64岁无肺炎球菌病高风险条件者25039人、19-64岁有高风险条件者16897人、≥65岁者5332人。
- 数据收集于2015年10月至2016年4月,分析于2016年9月至2017年6月。
- 干预组接受最多三次提醒/召回,对照组接受常规护理;主要结局为提醒/召回后≤6个月免疫信息系统中任何所需疫苗的接种记录。
主要发现
- 干预与≥65岁人群任何所需疫苗接种相关(AOR=1.15,95%CI=1.02,1.30),但与另两个人群无显著关联。
- 差异来源于流感疫苗:干预组32.0% vs 常规护理组28.6%(p≤0.01)。
- 人均启动和实施成本为0.86美元。
- ≥65岁人群中,需联系29.4名患者才能增加一次额外接种。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: A proven, but underutilized, method to increase current low vaccination rates is reminder/recall. Centralized reminder/recall using an Immunization Information System reduces the burden of an individual practice conducting reminder/recall. The objectives were to assess the effectiveness of centralized vaccine reminder/recall on improving adult vaccination rates using Colorado's Immunization Information System. STUDY DESIGN: This study is a pragmatic RCT. SETTING/PARTICIPANTS: Denver Health patients were divided into three strata: 25,039 individuals aged 19-64 years without a high-risk condition for pneumococcal disease, 16,897 individuals aged 19-64 years with a high-risk condition, and 5,332 individuals aged ≥65 years. Data were collected from October 2015 to April 2016 and analyzed between September 2016 and June 2017. INTERVENTION: Adults aged 19-64 years without a high-risk condition who needed influenza or tetanus, diphtheria, acellular pertussis vaccine or both, and adults with a high-risk condition and adults aged ≥65 years who needed influenza, or tetanus, diphtheria, acellular pertussis, or pneumococcal vaccine, or all three vaccines were randomized to receive up to three reminder/recalls or usual care. MAIN OUTCOME MEASURES: Documentation of receipt of any needed vaccine in Immunization Information System ≤6 months after the reminder/recall was the primary outcome. A secondary outcome included implementation costs of the reminder/recall effort. A mixed effects model assessed the association between the intervention and receipt of any needed vaccine while controlling for gender, age, race, ethnicity, insurance type, and history of vaccine refusal. RESULTS: The intervention was associated with receipt of any needed vaccine in the adults aged ≥65 years population (AOR=1.15, 95% CI=1.02, 1.30), but not the other two populations. Influenza vaccine was the source of this difference, with 32.0% receiving a vaccine in intervention versus 28.6% in usual-care groups (p≤0.01). Start-up and implementation costs per person were $0.86. In the population aged ≥65 years, 29.4 patients would need to be contacted to gain one additional vaccination. CONCLUSIONS: Centralized reminder/recall was effective at increasing influenza vaccination rates in adults aged ≥65 years over a short time period, without burdening the practices, and at a reasonable cost. TRIAL REGISTRATION: This study is registered at www.clinicaltrials.gov NCT02133391.
引用
- Hurley LP, Beaty B, Lockhart S, et al. RCT of Centralized Vaccine Reminder/Recall for Adults. Am J Prev Med. 2018. PMID: 29910118. doi:10.1016/j.amepre.2018.04.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。